Skip to content

A clinical trial to study a sensor system in patients with heart failure

Continuous Sensor Monitoring in Ambulatory Chronic Heart Failure (LAC-HF) - LAC HF

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111871
Enrollment
75
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I509- Heart failure, unspecified

Interventions

Intervention1: Abbott Sensor Based Monitoring System: The study intervention device would require the implantation of sensor-based system in Chronic Heart Failure patients for a total participation of

Sponsors

Abbott Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: At least 18 years of age with diagnosis of heart failure

Exclusion criteria

Exclusion criteria: Subject has known concomitant medical condition, in which, in the opinion of the investigator could present risk to the subject. Subject is currently participating in another interventional clinical trial For female participants, subject must not be pregnant or planning to become pregnant during the study.

Design outcomes

Primary

MeasureTime frame
Study the feasibility of sensor-based monitoring device in ambulatory patients with chronic heart failure.Timepoint: 90 Days

Secondary

MeasureTime frame
All cause readmissions Recurrent heart failure hospitalizations (HFH) or emergency department or hospital outpatient observation visits for intravenous diuretic therapy Six-Minute Hall Walk test at baseline & study completion NYHA assessment from baseline to study exit.Timepoint: 90 Days

Countries

India

Contacts

Public ContactSumit Anand

Abbott India Pvt. Ltd

sumit.anand@abbott.com01142600100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026